Pharmaceutical PVP, also called povidone or polyvinylpyrrolidone, is a water-soluble polymer used as an excipient in medicines and healthcare products. Its chemical name is poly(1-vinyl-2-pyrrolidone), and its commonly referenced CAS number is 9003-39-8. I typically see pharmaceutical PVP selected for tablet binding, solubilization, stabilization, film formation, and controlled processing performance. The appropriate grade depends mainly on molecular weight, K-value, dosage form, regulatory requirements, and the intended manufacturing process.
For more information, please visit our website.
Pharmaceutical PVP is a synthetic, nonionic, water-soluble polymer used in pharmaceutical formulations. It is produced by polymerizing N-vinyl-2-pyrrolidone and is supplied in different molecular-weight ranges identified by K-values or related viscosity measurements. The polymer can interact with water and many polar ingredients, which supports its use in both solid and liquid dosage forms.
PVP should not be treated as a single uniform product. A PVP K30 powder, for example, may behave differently from PVP K90 because molecular weight affects solution viscosity, binding strength, drying behavior, and film formation. For this reason, I advise buyers to specify the exact grade, applicable pharmacopeial standard, test method, and intended use rather than purchasing only by the general term “pharmaceutical PVP.”
The United States Pharmacopeia–National Formulary and the European Pharmacopoeia provide recognized quality frameworks for pharmaceutical excipients. Buyers should confirm which pharmacopeia, regional regulation, and internal quality standard apply to their product before approval. USP and the European Directorate for the Quality of Medicines & HealthCare are useful authoritative references for this evaluation.
PVP is widely considered as a binder for wet granulation and other tablet manufacturing processes. It helps powder particles adhere during granulation and may improve the mechanical integrity of compressed tablets. The required grade depends on the formulation, binder concentration, solvent system, granulation equipment, and target disintegration profile.
In practice, I would not assume that a higher K-value is automatically better. Excessive binding or excessive solution viscosity can make wetting, spraying, drying, and tablet disintegration more difficult. A formulation team may therefore compare several grades and concentrations, such as 1%, 3%, or 5%, during development rather than relying on a single default level.
PVP can improve the apparent solubility or dispersion of selected poorly water-soluble ingredients through polymer–ingredient interactions and amorphous solid dispersion approaches. Its suitability depends on the active ingredient, drug loading, processing temperature, moisture exposure, and storage conditions. Compatibility testing remains necessary because PVP does not solve every solubility or stability problem.
Because PVP can form transparent or continuous films after drying, it may be used in coatings, topical products, and certain liquid or semisolid formulations. It can also contribute to suspension or solution stability in selected systems. The final result depends on polymer grade, solids content, plasticizer selection, drying conditions, and interactions with other excipients.
For drug products, I recommend reviewing the intended use against approved excipient information in the target market. The U.S. Food and Drug Administration’s Inactive Ingredient Database can help buyers investigate historical routes of administration and dosage-form use, but it should not replace product-specific regulatory assessment.
PVP grades are commonly differentiated by K-value, which is related to solution viscosity and polymer molecular-weight characteristics. Common commercial references include K12, K15, K17, K25, K30, K60, and K90. These designations are useful for initial selection, but the buyer should verify the supplier’s test method and specification because K-value is not a complete description of product performance.
With competitive price and timely delivery, Yuking sincerely hope to be your supplier and partner.
| Grade family | Typical selection consideration | Potential application direction |
|---|---|---|
| PVP K12–K17 | Lower viscosity and easier handling in some dilute systems | Solubilization, liquid formulations, and specialized processing |
| PVP K25–K30 | Balanced binding and processing characteristics | Tablet binding, granulation, and general formulation development |
| PVP K60–K90 | Higher molecular-weight behavior and stronger viscosity or film contribution | Selected film-forming, stabilization, and high-viscosity applications |
The table is a practical starting point rather than a universal specification. A supplier may offer different grades, particle sizes, residual monomer limits, packaging formats, or compendial claims. I therefore recommend requesting a current specification sheet and certificate of analysis for the exact batch or production grade under consideration.
Most pharmaceutical PVP used as an excipient is supplied as a dry powder, while some manufacturers also offer prepared solutions or customized material forms. PVP/VA copolymers may be considered when a formulation requires a different balance of hydrophilicity, film formation, or solid-dispersion performance. These materials should not be treated as direct substitutes for homopolymer PVP without formulation and regulatory review.
When I evaluate pharmaceutical PVP for a B2B project, I begin with identity and grade confirmation. The documentation should clearly identify the polymer, grade or K-value, applicable pharmacopeial standard, manufacturing site, lot number, and retest or expiry information where applicable. The buyer should also confirm whether the supplier can provide traceable batch documentation for every shipment.
Exact acceptance limits should come from the current official monograph, approved product specification, or agreed quality agreement. I avoid presenting one universal numerical limit because requirements can differ by grade, market, dosage form, and analytical method.
First, define the dosage form and manufacturing route: wet granulation, dry blending, coating, liquid preparation, topical processing, or solid dispersion. Then identify whether the main requirement is binding, solubilization, viscosity control, film formation, or stabilization. This process-based approach is usually more reliable than selecting a grade only by price or a familiar product name.
Before issuing a purchase order, I recommend requesting the technical data sheet, specification, representative certificate of analysis, safety data sheet, country of origin, packaging details, and change-notification policy. If the material will enter a regulated drug supply chain, the buyer should also clarify quality agreements, audit expectations, manufacturing-site information, and document retention. Supplier statements should be checked against the buyer’s own regulatory and quality requirements.
Price per kilogram is only one part of the purchasing decision. I also compare minimum order quantity, standard packing weight, lead time, production capacity, forecast flexibility, sample availability, shipping conditions, and the supplier’s ability to maintain consistent specifications. For a development project, a small evaluation sample may be more valuable than a low unit price that cannot be supported by reliable replenishment.
Yuking can support B2B buyers by helping clarify the intended application, reviewing the requested PVP grade, supplying available technical documents, and coordinating samples or commercial quotations subject to project requirements. I recommend that buyers send the target grade, dosage form, annual demand, destination market, packaging preference, and required documents so that the inquiry can be evaluated accurately. Any final pharmaceutical use should remain subject to the buyer’s formulation, quality, and regulatory approval process.
Pharmaceutical PVP is a versatile water-soluble polymer excipient used mainly for binding, solubilization, stabilization, and film formation. Its grades are commonly differentiated by K-value, with examples ranging from K12 to K90, but the correct choice depends on the formulation and manufacturing process rather than the grade name alone. Buyers should evaluate both functional performance and documented quality attributes such as viscosity, residual N-vinylpyrrolidone, moisture, ash, pH, and microbiological quality.
My recommended next step is to prepare a clear technical inquiry containing the intended application, target PVP grade, required standard, annual volume, packaging, destination market, and documentation needs. Yuking can then help review the requirement and provide available product and supply information for evaluation. After laboratory testing and quality approval, the buyer can proceed with a quotation, sample order, and commercial supply plan based on verified specifications.
Want more information on pharmaceutical pvp? Feel free to contact us.